Nilotinib Olpha 200 mg tvrde kapsule
| Name | Nilotinib Olpha 200 mg tvrde kapsule |
|---|---|
| Marketing Authorisation Number | HR-H-630938483 |
| Active Substance | nilotinibklorid hidrat |
| Composition | jedna tvrda kapsula sadrži 200 mg nilotiniba (u obliku nilotinibklorid hidrata) |
| Pharmaceutical Form | Kapsula, tvrda |
| Manufacturer | Bluepharma Industria Farmaceutica S.A., Coimbra, Portugal
Bluepharma Industria Farmaceutica S.A., Coimbra, Portugal |
| Marketing Authorisation Holder | Olpha AS, Rupnicu Iela 5, Olaine, Olaines Novads, Latvija |
| Marketing Authorisation Date | 03.07.2026 |
| MA Period of Validity | 03.07.2031 |
| Classification Number | UP/I-530-09/24-01/243 |
| Registration Number | 381-12-01/171-26-07 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | L01EA03 |
| Marketing status | Never marketed |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |